Homeostatic mechanisms regulating mast cell numbers and function in periphe
ral tissues have largely focused on cytokines, such as stem cell factor, in
terleukin (IL)-3, IL-4, and IL-10, which regulate mast cell maintenance and
proliferation. Despite these advances, little attention has been paid to t
he mechanisms that mediate mature mast cell turnover, and control of mast c
ell hyperplasia generated during Th2-mediated responses. These are importan
t issues, as mast cells are now known to be multi-functional effector cells
, that have the capacity to mediate both innate and Th2-induced immune resp
onses. Numerous secretagogues may elicit mast cells to release a large numb
er of important mediators that can cause chronic inflammation. Therefore, h
ow mast cell homeostasis is regulated may have significant effects on norma
l physiology, and contribute to the genesis of inflammatory disease. Our la
boratory has characterized an in vitro model of mast cell homeostasis, by w
hich long-term exposure of murine bone-marrow-derived mast cells to the Th2
-derived cytokines IL-3, IL-4, and IL-10, will induce downregulation of cri
tical mast cell effector proteins such as Kit and Fc epsilon RI, followed b
y mast cell apoptosis. These data offer a novel role for Th2 cytokines, act
ing to both initiate and resolve mast cell activation and proliferation. Lo
ss of these signals may contribute to a multitude of diseases, such as mast
ocytosis and allergy.